Alnylam Pharmaceuticals (ALNY) Income towards Parent Company (2009 - 2026)
Alnylam Pharmaceuticals' Income towards Parent Company was $164.49 million in Q2 2026, compared with -$72.23 million a year earlier and down 20.1% from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Income towards Parent Company (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Alnylam Pharmaceuticals' Income towards Parent Company was $733.11 million through Jun 30, 2026; for FY2025, it was $313.75 million.
- In earlier years, Income towards Parent Company was -$278.16 million in FY2024, -$440.24 million in FY2023, -$1.13 billion in FY2022 and -$852.82 million in FY2021.
- Quarterly Income towards Parent Company has moved between -$405.92 million (Q3 2022) and $251.08 million (Q3 2025) over five years.
- Per Business Quant data, ALNY's Income towards Parent Company in the three quarters before Q2 2026 was $205.99 million (Q1 2026), $111.54 million (Q4 2025) and $251.08 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn |
| 10 | Alnylam Pharmaceuticals | 34.23 Bn | 22.28 Bn | 992.69 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 164.49 Mn |
| Mar 31, 2026 | 205.99 Mn |
| Dec 31, 2025 | 111.54 Mn |
| Sep 30, 2025 | 251.08 Mn |
| Jun 30, 2025 | -72.23 Mn |
| Mar 31, 2025 | -18.25 Mn |
| Dec 31, 2024 | -83.76 Mn |
| Sep 30, 2024 | -111.57 Mn |
| Jun 30, 2024 | -16.89 Mn |
| Mar 31, 2024 | -65.94 Mn |
| Dec 31, 2023 | -137.87 Mn |
| Sep 30, 2023 | 147.75 Mn |
| Jun 30, 2023 | -276.02 Mn |
| Mar 31, 2023 | -174.10 Mn |
| Dec 31, 2022 | -207.49 Mn |
| Sep 30, 2022 | -405.92 Mn |
| Jun 30, 2022 | -277.40 Mn |
| Mar 31, 2022 | -240.34 Mn |
| Dec 31, 2021 | -258.46 Mn |
| Sep 30, 2021 | -204.51 Mn |
API Access
Alnylam Pharmaceuticals Income towards Parent Company API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "income-towards-parent-company", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=income-towards-parent-company&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();